Delivery Order SPE2DE24D0013-SPE2D625F1Y0B

Award Date 4/8/25
Potential Completion Date 4/15/25
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a delivery order worth $4,539.30 with a firm fixed price pricing type and an ultimate completion date of April 18, 2025. Cepheid, the prime contractor, will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, test kits, and maintenance services, to support the detection of infectious diseases...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $2,208.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting a variety of infectious diseases, including COVID-19, influenza, and sexually transmitted diseases....
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The $7,262.88 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other conditions. Cepheid holds several significant federal contract Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract has a ceiling value of $28,875.00 and an ultimate completion date of February 14, 2025. Cepheid will provide the agency with molecular diagnostic testing equipment, reagents, and consumables, primarily for the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency (DLA) for the supply of diagnostic testing equipment, reagents, and consumables for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $27,200.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid holds several significant federal contract Indefinite Delivery...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of diagnostic testing equipment, reagents, and consumables. The contract, valued at $1,361.79, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA). It does not have a set-aside designation. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. Under this contract,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $1,605.00, is a firm fixed-price delivery order with no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) vehicle with the DLA. Under this contract, Cepheid will provide molecular diagnostic testing equipment, reagents, test kits, and maintenance services...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $17,000.00 and an ultimate completion date of May 14, 2025. The contract is for the provision of XPCOV2/FLU/RSV-10 diagnostic products, which are likely molecular tests for COVID-19, influenza, and respiratory syncytial virus. Cepheid is an experienced federal contractor, holding several...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F1Y0B
    Delivery Order

This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) to provide molecular diagnostic testing equipment, reagents, and consumables. The $1,840.00 firm fixed-price delivery order contract has an ultimate completion date of April 15, 2025. Cepheid has provided similar molecular diagnostic testing solutions, including for COVID-19, influenza, and other infectious diseases, to federal agencies such as the Department of Veterans Affairs (VA) and Indian Health Service through other Indefinite Delivery Vehicles (IDVs). This contract does not have a set-aside designation. Cepheid has also participated as a subrecipient on federal grant awards, collaborating with academic institutions and other organizations on specialized research projects related to diagnostic testing capabilities.

Generated 7/8/25, 2:19 PM